BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coyle C, Campbell RE. Pathological pulses in PCOS. Mol Cell Endocrinol 2019;498:110561. [PMID: 31461666 DOI: 10.1016/j.mce.2019.110561] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Stevenson H, Bartram S, Charalambides MM, Murthy S, Petitt T, Pradeep A, Vineall O, Abaraonye I, Lancaster A, Koysombat K, Patel B, Abbara A. Kisspeptin-neuron control of LH pulsatility and ovulation. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.951938] [Reference Citation Analysis]
2 Emanuel RHK, Roberts J, Docherty PD, Lunt H, Campbell RE, Möller K. A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1017468] [Reference Citation Analysis]
3 Astuto MC, Benford D, Bodin L, Cattaneo I, Halldorsson T, Schlatter J, Sharpe RM, Tarazona J, Younes M. Applying the adverse outcome pathway concept for assessing non-monotonic dose responses: biphasic effect of bis(2-ethylhexyl) phthalate (DEHP) on testosterone levels. Arch Toxicol 2022. [DOI: 10.1007/s00204-022-03409-9] [Reference Citation Analysis]
4 Wang Y, Ma Y, Liu H, Cui Z, Zhao D, Zhang X, Zhang L, Guo W, Long Y, Tu S, Yuan D, Zhang J, Wang B, Xu L, Shen Q, Wang Y, Nie L, Yue L. Hyperandrogen-induced polyol pathway flux increase affects ovarian function in polycystic ovary syndrome via excessive oxidative stress. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.121224] [Reference Citation Analysis]
5 Yang X, Jiang M, Deng M, Zhang H, Lin Z, Fei X, Zhang H. Clomiphene citrate mild stimulation improved follicular development outcomes in PCOS women with high luteinizing hormone and poor ovarian response: A case report. Medicine (Baltimore) 2022;101:e31323. [PMID: 36281179 DOI: 10.1097/MD.0000000000031323] [Reference Citation Analysis]
6 Wang Y, Chen J, Dong H, Ma R, Zou Y, Wang W, Zheng Q, Feng Y, Tan Z, Zeng X, Zhao Y, Deng Y, Wang Y, Gu B, Sun A, Khan NR. The Disparity in the Management of Polycystic Ovary Syndrome between Obstetrician-Gynecologists in Different-Level Hospitals under the Hierarchical Medical System. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/9778678] [Reference Citation Analysis]
7 Xing L, Xu J, Wei Y, Chen Y, Zhuang H, Tang W, Yu S, Zhang J, Yin G, Wang R, Zhao R, Qin D. Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment. Front Psychiatry 2022;13:1001484. [DOI: 10.3389/fpsyt.2022.1001484] [Reference Citation Analysis]
8 Yuan B, Luo S, Feng L, Wang J, Mao J, Luo B. Resveratrol regulates the inflammation and oxidative stress of granulosa cells in PCOS via targeting TLR2. J Bioenerg Biomembr 2022. [PMID: 35836030 DOI: 10.1007/s10863-022-09942-7] [Reference Citation Analysis]
9 Yang T, Yang Y, Zhang Q, Liu D, Liu N, Li Y, Yao Z, Zhang Y, Tian F, Zhao J, Li Y. Homeostatic Model Assessment for Insulin Resistance Is Associated With Late Miscarriage in Non-Dyslipidemic Women Undergoing Fresh IVF/ICSI Embryo Transfer. Front Endocrinol 2022;13:880518. [DOI: 10.3389/fendo.2022.880518] [Reference Citation Analysis]
10 Li Y, Zhi W, Haoxu D, Qing W, Ling C, Ping Y, Dongmei H. Effects of electroacupuncture on the expression of hypothalamic neuropeptide Y and ghrelin in pubertal rats with polycystic ovary syndrome. PLoS ONE 2022;17:e0259609. [DOI: 10.1371/journal.pone.0259609] [Reference Citation Analysis]
11 Duane M, Stanford JB, Porucznik CA, Vigil P. Fertility Awareness-Based Methods for Women's Health and Family Planning. Front Med (Lausanne) 2022;9:858977. [PMID: 35685421 DOI: 10.3389/fmed.2022.858977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wei L, Wu F, Zhang J, Li J, Yang D, Wen G, Koundal D. Evaluation of Endocrine and Metabolic Changes in Polycystic Ovary Syndrome by Ultrasonic Imaging Features under an Intelligent Algorithm. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/1411943] [Reference Citation Analysis]
13 Szeliga A, Rudnicka E, Maciejewska-jeske M, Kucharski M, Kostrzak A, Hajbos M, Niwczyk O, Smolarczyk R, Meczekalski B. Neuroendocrine Determinants of Polycystic Ovary Syndrome. IJERPH 2022;19:3089. [DOI: 10.3390/ijerph19053089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang W, Liang T, Han B, Yang R, Yang S, Yang Y, Zhang J, Zheng X, Yan J, Ma C, Song X, Qiao J. Clinical Outcomes of In Vitro Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study. Front Endocrinol 2022;13:842037. [DOI: 10.3389/fendo.2022.842037] [Reference Citation Analysis]
15 Moore AM, Coolen LM, Lehman MN. In vivo imaging of the GnRH pulse generator reveals a temporal order of neuronal activation and synchronization during each pulse. Proc Natl Acad Sci U S A 2022;119:e2117767119. [PMID: 35110409 DOI: 10.1073/pnas.2117767119] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
16 Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci 2022;23:583. [PMID: 35054768 DOI: 10.3390/ijms23020583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Marcus E, Haines K, Gressel GM. Endometrial Cancer and Precancer in Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 2022. [DOI: 10.1007/978-3-030-92589-5_21] [Reference Citation Analysis]
18 Ho EV, Shi C, Cassin J, He MY, Nguyen RD, Ryan GE, Tonsfeldt KJ, Mellon PL. Reproductive Deficits Induced by Prenatal Antimüllerian Hormone Exposure Require Androgen Receptor in Kisspeptin Cells. Endocrinology 2021;162:bqab197. [PMID: 34529765 DOI: 10.1210/endocr/bqab197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Li Y, Zhi W, Haoxu D, Qing W, Ling C, Ping Y, Dongmei H. Effects of electroacupuncture on the expression of hypothalamic neuropeptide Y and ghrelin in pubertal rats with polycystic ovary syndrome.. [DOI: 10.1101/2021.10.25.465707] [Reference Citation Analysis]
20 Moore AM, Coolen LM, Lehman MN. In vivo imaging of the GnRH pulse generator reveals a temporal order of neuronal activation and synchronization during each pulse.. [DOI: 10.1101/2021.10.13.464231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Berthon A, Settas N, Delaney A, Giannakou A, Demidowich A, Faucz FR, Seminara SB, Chen ME, Stratakis CA. Kisspeptin deficiency leads to abnormal adrenal glands and excess steroid hormone secretion. Hum Mol Genet 2020;29:3443-50. [PMID: 33089319 DOI: 10.1093/hmg/ddaa215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Moore AM, Lohr DB, Coolen LM, Lehman MN. Prenatal Androgen Exposure Alters KNDy Neurons and Their Afferent Network in a Model of Polycystic Ovarian Syndrome. Endocrinology 2021;162:bqab158. [PMID: 34346492 DOI: 10.1210/endocr/bqab158] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
23 Stener-Victorin E, Padmanabhan V, Walters KA, Campbell RE, Benrick A, Giacobini P, Dumesic DA, Abbott DH. Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome. Endocr Rev 2020;41:bnaa010. [PMID: 32310267 DOI: 10.1210/endrev/bnaa010] [Cited by in Crossref: 90] [Cited by in F6Publishing: 101] [Article Influence: 90.0] [Reference Citation Analysis]
24 Zhou L, Han X, Li W, Wang N, Yao L, Zhao Y, Zhang L. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2. Reprod Sci 2021. [PMID: 34254281 DOI: 10.1007/s43032-021-00664-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
25 Dinsdale NL, Crespi BJ. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl 2021;14:1693-715. [PMID: 34295358 DOI: 10.1111/eva.13244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
26 Wide L, Naessén T, Sundström-Poromaa I, Eriksson K. Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome. J Endocr Soc 2021;5:bvab080. [PMID: 34159285 DOI: 10.1210/jendso/bvab080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ozegowska K, Korman M, Szmyt A, Pawelczyk L. Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia-A New Insight on Syndrome Pathogenesis. Int J Environ Res Public Health 2020;17:E9291. [PMID: 33322590 DOI: 10.3390/ijerph17249291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab 2021;106:e1071-83. [PMID: 33211867 DOI: 10.1210/clinem/dgaa839] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 27.0] [Reference Citation Analysis]
29 Forslund M, Schmidt J, Brännström M, Landin-wilhelmsen K, Dahlgren E. Reproductive Hormones and Anthropometry: A Follow-Up of PCOS and Controls From Perimenopause to Older Than 80 Years. The Journal of Clinical Endocrinology & Metabolism 2021;106:421-30. [DOI: 10.1210/clinem/dgaa840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Wawrzkiewicz-Jałowiecka A, Kowalczyk K, Trybek P, Jarosz T, Radosz P, Setlak M, Madej P. In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond. Int J Mol Sci 2020;21:E7054. [PMID: 32992734 DOI: 10.3390/ijms21197054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
31 Mut A, Erel CT, İnan D, Öner YÖ. Serum kisspeptin levels correlated with anti-mullerian hormone levels in women with and without polycystic ovarian syndrome. Gynecological Endocrinology 2021;37:462-6. [DOI: 10.1080/09513590.2020.1825670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Doretto L, Mari FC, Chaves AC. Polycystic Ovary Syndrome and Psychotic Disorder. Front Psychiatry 2020;11:543. [PMID: 32587538 DOI: 10.3389/fpsyt.2020.00543] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
33 Kauffman AS, Hoffmann HM. Editorial: Hormone release patterns in mammals. Mol Cell Endocrinol 2020;507:110781. [PMID: 32119896 DOI: 10.1016/j.mce.2020.110781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]